IsoRay Likely Has Further To Rise [Seeking Alpha]
IsoRay, Inc. (DE) (ISR)
NASDAQ:AMEX Investor Relations:
isoray.com
Company Research
Source: Seeking Alpha
Summary The company's Cesium-131 based cancer treatments are effective, cheap and produce less side effects than other radiation. The company's market cap is small in relation to its first big target market, prostate cancer. But there is another big market in treating brain cancer and a number of smaller additional applications. The company is displaying impressive revenue growth, margin improvement and it isn't bleeding much cash anymore. We argued ISR So it's a little disappointing that this hasn't been reflected in the share price, at least not until very recently: While the improvement has been steady, the shares have lingered and only recently taken off in a parabolic fashion. In a sense, this actually didn't come all that unexpectedly, as we wrote previously: Their Cesium-131 based brachytherapy solutions show a lot of promise, not only in combating prostate cancer where they get most of their revenues. The company has a chance to scale up with the FDA approval, but they will ha
Show less
Read more
Impact Snapshot
Event Time:
ISR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ISR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ISR alerts
High impacting IsoRay, Inc. (DE) news events
Weekly update
A roundup of the hottest topics